Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide.
暂无分享,去创建一个
[1] G. Welch,et al. Nitric Oxide and the Cardiovascular System , 2000, Contemporary Cardiology.
[2] J. Loscalzo,et al. Nitric Oxide Inhibits Thrombin Receptor-activating Peptide-induced Phosphoinositide 3-Kinase Activity in Human Platelets* , 1999, The Journal of Biological Chemistry.
[3] J. Loscalzo,et al. Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. , 1998, Circulation.
[4] W. Sessa,et al. Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Carmeliet,et al. Low levels of tissue factor are compatible with development and hemostasis in mice. , 1998, The Journal of clinical investigation.
[6] B. Østerud. Tissue Factor: a Complex Biological Role , 1997, Thrombosis and Haemostasis.
[7] J. Fallon,et al. Tissue Factor in the Pathogenesis of Atherosclerosis , 1997, Thrombosis and Haemostasis.
[8] B. Osterud,et al. Tissue Factor: a Complex Biological Role , 1997, Thrombosis and Haemostasis.
[9] J. Fallon,et al. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[10] J. Loscalzo,et al. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. , 1996, The Journal of clinical investigation.
[11] Y. Yu,et al. Coinduction of Nitric Oxide Synthase, Argininosuccinate Synthetase, and Argininosuccinate Lyase in Lipopolysaccharide-treated Rats , 1996, The Journal of Biological Chemistry.
[12] J. Loscalzo,et al. Nitric oxide and its role in the cardiovascular system. , 1995, Progress in cardiovascular diseases.
[13] S. Rapaport,et al. The Tissue Factor Pathway: How It Has Become a “Prima Ballerina” , 1995, Thrombosis and Haemostasis.
[14] C. Lowenstein,et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. , 1995, The American journal of physiology.
[15] J. Loscalzo,et al. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP. , 1995, The American journal of physiology.
[16] C. Lowenstein,et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1β and IFN-γ , 1995 .
[17] S Amerini,et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.
[18] P. Peristeris,et al. Evidence that nitric oxide is an endogenous antiangiogenic mediator , 1994, British journal of pharmacology.
[19] J. Pearson,et al. Vessel wall interactions regulating thrombosis. , 1994, British medical bulletin.
[20] J. Stamler,et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[21] H. Anderson,et al. Endogenous Nitric Oxide Protects Against Platelet Aggregation and Cyclic Flow Variations in Stenosed and Endothelium‐Injured Arteries , 1992, Circulation.
[22] S. Abramson,et al. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. , 1992, The Journal of clinical investigation.
[23] E. Jaffe,et al. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. , 1991, Biochemical and biophysical research communications.
[24] N. Mackman,et al. The Structural Biology of Expression and Function of Tissue Factor , 1991, Thrombosis and Haemostasis.
[25] R. Palmer,et al. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] S. Moncada,et al. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Loscalzo,et al. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. , 1990, The Journal of biological chemistry.
[28] Kathleen M. Smith,et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] Y. Nemerson. Tissue factor and hemostasis. , 1988, Blood.
[30] L. Ignarro,et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Esmon,et al. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. , 1987, The Journal of clinical investigation.
[32] W. Fiers,et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[34] W. Kisiel,et al. Self-regulation of procoagulant events on the endothelial cell surface , 1985, The Journal of experimental medicine.
[35] R. Cotran,et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.
[36] N. Semeraro,et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. , 1983, The Journal of clinical investigation.
[37] Y. Nemerson,et al. [5] Purification and characterization of tissue factor apoprotein , 1976 .
[38] Y. Nemerson,et al. Purification and characterization of tissue factor apoprotein. , 1976, Methods in enzymology.
[39] B. Saville. A scheme for the colorimetric determination of microgram amounts of thiols , 1958 .